1,4-dihydropyridine has been researched along with Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajpai, A; Mishra, AP; Rai, AK | 1 |
| Basak, J; Bhuyan, R; Ghosh, R; Ghosh, S; Manna, D; Saikh, F | 1 |
| Firuzi, O; Javidnia, K; Miri, R; Nazari, F; Sadeghpour, H; Saso, L; Shekari, F | 1 |
| Altucci, L; Atlante, S; Budriesi, R; Carafa, V; Carnevale, I; Cencioni, C; Del Bufalo, D; Gabellini, C; Gaetano, C; Mai, A; Mellini, P; Moniot, S; Nebbioso, A; Polletta, L; Saladini, S; Spallotta, F; Steegborn, C; Tafani, M; Tardugno, M; Trisciuoglio, D; Valente, S; Zwergel, C | 1 |
| Jain, N; Kakadiya, R; Mirza, S; Rathod, A; Rawal, R; Shah, A; Shaikh, F; Viradiya, D | 1 |
| Hadizadeh, F; Iman, M; Mollazadeh, S; Shamsara, J | 1 |
| Baumert, C; Günthel, M; Hemmer, M; Hilgeroth, A; Krawczyk, S; Lage, H; Langner, A; Molnár, J; Wersig, T | 1 |
| Daly, AK; Hall, AG | 1 |
| Hilgeroth, A; Molnár, J; Richter, M | 1 |
| Alderighi, D; D'Elia, P; Dragoni, S; Fusi, F; Kawase, M; Motohashi, N; Saponara, S; Sgaragli, G; Sgaragli, T; Shah, A; Valoti, M | 1 |
| Kiue, A; Kohno, K; Kuwano, M; Takano, H; Watanabe, Y | 1 |
3 review(s) available for 1,4-dihydropyridine and Neoplasms
| Article | Year |
|---|---|
1,4-Dihydropyridine: A Dependable Heterocyclic Ring with the Promising and the Most Anticipable Therapeutic Effects.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antihypertensive Agents; Antineoplastic Agents; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Heterocyclic Compounds; Neoplasms; Ulcer | 2019 |
Pharmacogenetics of cytotoxic drugs.
Topics: Antineoplastic Agents; Arylamine N-Acetyltransferase; Cytochrome P-450 Enzyme System; Cytotoxins; Dihydropyridines; Glucuronosyltransferase; Humans; Methyltransferases; Neoplasms; Oxidoreductases; Pharmacogenetics; Polymorphism, Genetic | 2001 |
Cancer cell permeability-glycoprotein as a target of MDR reverters: possible role of novel dihydropyridine derivatives.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Dihydropyridines; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Neoplasms; Permeability | 2006 |
8 other study(ies) available for 1,4-dihydropyridine and Neoplasms
| Article | Year |
|---|---|
Novel 1,4-dihydropyridine induces apoptosis in human cancer cells through overexpression of Sirtuin1.
Topics: A549 Cells; Apoptosis; Dihydropyridines; Gene Expression Regulation, Neoplastic; HeLa Cells; Hep G2 Cells; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasms; Oncogene Protein v-akt; Sirtuin 1; Survivin | 2018 |
Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Calcium Channels; Cell Line, Tumor; Dihydropyridines; Doxorubicin; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Inhibitory Concentration 50; Molecular Structure; Neoplasm Proteins; Neoplasms; Stereoisomerism; Structure-Activity Relationship | 2015 |
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondrial Function and Exhibit Inhibition of Proliferation in Cancer Cells.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Dihydropyridines; Enzyme Activation; Humans; Male; Mice; Mitochondria; Neoplasms; Signal Transduction; Sirtuin 1; Skin; Wound Healing | 2016 |
Design and Synthesis of 1,4-dihydropyridine Derivatives as Anti-cancer Agent.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dihydropyridines; Drug Screening Assays, Antitumor; Humans; Neoplasms; Structure-Activity Relationship | 2017 |
Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent.
Topics: Antineoplastic Agents; Dihydropyridines; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Least-Squares Analysis; Linear Models; Models, Molecular; Molecular Docking Simulation; Neoplasms; Quantitative Structure-Activity Relationship | 2017 |
Development of small-molecule P-gp inhibitors of the N-benzyl 1,4-dihydropyridine type: novel aspects in SAR and bioanalytical evaluation of multidrug resistance (MDR) reversal properties.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Daunorubicin; Dihydropyridines; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Mice; Neoplasms; Structure-Activity Relationship | 2013 |
Biological evaluation of bishydroxymethyl-substituted cage dimeric 1,4-dihydropyridines as a novel class of p-glycoprotein modulating agents in cancer cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Proliferation; Dihydropyridines; Dimerization; Hydroxylation; Methylation; Mice; Molecular Structure; Neoplasms; Structure-Activity Relationship | 2006 |
Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistant and atypical multidrug-resistant human cancer cells.
Topics: Antineoplastic Agents; Cell Survival; Dihydropyridines; Dioxins; Drug Resistance; Drug Synergism; Etoposide; Humans; Intracellular Fluid; Neoplasms; Tritium; Tumor Cells, Cultured; Vincristine | 1991 |